Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 26 Prostatic Neoplasms 24 Brain Neoplasms 21 Neoplasms 13 Glioma 10 Head and Neck Neoplasms 8 Pancreatic Neoplasms 7 Glioblastoma 6 Lung Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Hepatocellular 5 Astrocytoma 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Rectal Neoplasms 4 Lymphoma 4 Central Nervous System Neoplasms 4 Urinary Bladder Neoplasms 3 Triple Negative Breast Neoplasms 3 Spinal Cord Neoplasms 3 Sarcoma 3 Liver Neoplasms 3 Disease 3 Retinoblastoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pathologic Complete Response 2 Oligodendroglioma 2 Neurofibromatosis 1 2 Meningioma 2 Lymphoma, Non-Hodgkin 2

Interventions

Etoposide 79 Carboplatin 67 Cisplatin 58 durvalumab 29 Irinotecan 29 Radiotherapy 27 atezolizumab 23 Topotecan 21 anlotinib 19 Nivolumab 15 Drug Therapy 15 Radiosurgery 14 Gemcitabine 13 apatinib 12 Paclitaxel 12 toripalimab 10 Platinum 10 Docetaxel 10 tislelizumab 9 Temozolomide 9 PM 01183 8 pembrolizumab 7 olaparib 7 Magnetic Resonance Spectroscopy 7 Ipilimumab 7 Bevacizumab 7 Albumin-Bound Paclitaxel 7 irinotecan sucrosofate 6 Counseling 6 sintilimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Small Cell Lung Carcinoma × Magnetic Resonance Imaging × Clear all

NCT04168281 2019-11-19

PCILESS

University of Warmia and Mazury in Olsztyn

Phase NA Unknown

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡